Last reviewed · How we verify
INN805
At a glance
| Generic name | INN805 |
|---|---|
| Sponsor | FindCure Biosciences (ZhongShan) Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- INN805 CI brief — competitive landscape report
- INN805 updates RSS · CI watch RSS
- FindCure Biosciences (ZhongShan) Co., Ltd. portfolio CI